Biogen Pharmachem Industries share news, announcements and annual reports
BIOGEN PHARMACHEM INDUSTRIES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹0.25₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.25.
30 Oct: open ₹0.25, high ₹0.25, low ₹0.24
52-week range of traded prices to 30 Oct 2026
₹0.23Low, 23 Oct 2026₹0.72High, 4 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 23,53,079
Biogen Pharmachem Industries shareholder meetings
56 filed, newest first. Page 2 of 2.
Aug 2012
21 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from August 30, 2012 to August 31, 2012 for the purpose of ....
Jun 2011
29 Jun · Meeting
Members at the Annual General Meeting (AGM) of the Company held on June 29, 2011, inter alia, have taken the following decisions: 1. ....1 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from June 21, 2011 to June 28, 2011 (both days inclusive) for ....
May 2011
12 May · Meeting
Shareholders at the Extra Ordinary General Meeting (EGM) of the Company held on May 12, 2011, inter alia, have taken the following decisions: ....
Sep 2010
30 Sep · Meeting
Members at the Annual General Meeting (AGM) of the Company held on September 30, 2010, inter alia, have taken the following decisions : ....7 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2010 to September 30, 2010 (both days inclusive) ....